Bloomberg - Are you a robot?
Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing… Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times…
Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing… Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing…
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.